Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by ...

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to ...

Sanofi’s Sarclisa (isatuximab) has been approved by the European Commission (EC) to treat newly diagnosed multiple myeloma ...

Listening to patients and HCPs helps strike the right notes to deliver harmony across engagement and activation ...

Eli Lilly’s Alzheimer’s disease (AD) drug donanemab has been recommended by the European Medicines Agency’s human medicines ...

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and ...

Merck & Co – known as MSD outside of the US and Canada – has unveiled a new cost-cutting plan aimed at saving $3bn every year ...

Walawalkar most recently served as chief strategy officer, international brands at MullenLowe Global, part of IPG ...

Moderna’s LP.8.1-adapted COVID-19 vaccine has been recommended by the European Medicines Agency (EMA)’s human medicines ...

Our strategist Stephanie Goley, MSc, PhD takes a fascinating look at how advertising is breaking down stigmas around areas of ...

AstraZeneca’s Imfinzi (durvalumab) has been granted priority review by the US Food and Drug Administration (FDA) to treat ...

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by ...